Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NextCell Pharma AB | 1,944,440 | net | 16 Jun 2025 | tx 22+2,361,720−417,280 |
| Hangethe Consulting AB | 715,000 | net | 11 Jun 2024 | tx 1+715,000 |
| Sprint Bioscience AB | 1,000 | net | 29 Oct 2020 | tx 1+1,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jun 2025 | PURCHASE | NextCell Pharma AB | 218,389 | 1.02 SEK | |
| 16 Jun 2025 | PURCHASE | NextCell Pharma AB | 198,891 | 0.99 SEK | |
| 13 Jun 2025 | SALE | NextCell Pharma AB | 217,389 | 0.99 SEK | |
| 16 Jun 2025 | SALE | NextCell Pharma AB | 199,891 | 0.98 SEK | |
| 31 May 2025 | PURCHASE | NextCell Pharma AB | 298,440 | 1.00 SEK | |
| 30 May 2025 | PURCHASE | NextCell Pharma AB | 1,320 | 1.00 SEK | |
| 27 May 2025 | PURCHASE | NextCell Pharma AB | 20,000 | 0.01 SEK | derivanomaly |
| 09 May 2025 | PURCHASE | NextCell Pharma AB | 50,000 | 0.08 SEK | deriv |
| 28 Apr 2025 | PURCHASE | NextCell Pharma AB | 100,000 | 0.09 SEK | deriv |
| 18 Dec 2024 | PURCHASE | NextCell Pharma AB | 15,000 | 2.36 SEK | |
| 18 Dec 2024 | PURCHASE | NextCell Pharma AB | 40,000 | 0.63 SEK | deriv |
| 14 Jun 2024 | PURCHASE | NextCell Pharma AB | 71,500 | 1.06 SEK | |
| 14 Jun 2024 | PURCHASE | NextCell Pharma AB | 16,940 | 1.06 SEK | |
| 14 Jun 2024 | PURCHASE | NextCell Pharma AB | 1,320 | 1.06 SEK | |
| 11 Jun 2024 | PURCHASE | Hangethe Consulting AB | 715,000 | 0.03 SEK | deriv |
| 24 Aug 2023 | PURCHASE | NextCell Pharma AB | 7,900 | 3.90 SEK | first after silence |
| 24 Aug 2023 | PURCHASE | NextCell Pharma AB | 5,000 | 3.85 SEK | |
| 24 Aug 2023 | PURCHASE | NextCell Pharma AB | 2,500 | 3.95 SEK | |
| 29 Oct 2020 | PURCHASE | Sprint Bioscience AB | 1,000 | 7.44 SEK |
1 purchase reported after at least 12 months of silence — most recent on 24 Aug 2023.